APO Research
Talk to an analyst

APO RESEARCH · REPORT

Monooxygenase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Monooxygenase Market Outlook and Growth Opportunities 2026

13 August 2026194 pages

Choose your research edition.

Industry ResearchMonooxygenase Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Monooxygenase Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Monooxygenase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Monooxygenase Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Monooxygenase Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Monooxygenase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Monooxygenase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Monooxygenase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Monooxygenase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Monooxygenase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Monooxygenase market include Codexis, Almac Group, Prozomix, InnoSyn, Nanjing Predicte Biotechnology, SyncoZymes, Asymchem, WuXi STA and Tianjin Bio-Pharmacn Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Monooxygenase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Monooxygenase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Monooxygenase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Monooxygenase market size, projected growth trends, production technologies, key applications, and end-use industries.

Monooxygenase Segment by Company

Codexis

Almac Group

Prozomix

InnoSyn

Nanjing Predicte Biotechnology

SyncoZymes

Asymchem

WuXi STA

Tianjin Bio-Pharmacn Biotechnology

Monooxygenase Segment by Type

P450 Type

Flavin-dependent Type

Non-heme Iron Type

Monooxygenase Segment by Application

Pharmaceutical Biocatalysis

Agrochemical Intermediate

Flavor and Fragrance

Environmental Remediation

Other

Monooxygenase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Monooxygenase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Monooxygenase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Monooxygenase significant trends, drivers, influence factors in global and regions.

6. To analyze Monooxygenase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monooxygenase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Monooxygenase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monooxygenase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Monooxygenase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Monooxygenase industry.

Chapter 3: Detailed analysis of Monooxygenase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Monooxygenase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Monooxygenase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Monooxygenase Industry Trends Table 2. Monooxygenase Industry Drivers Table 3. Monooxygenase Industry Opportunities and Challenges Table 4. Monooxygenase Industry Restraints Table 5. Global Monooxygenase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Monooxygenase Revenue Share by Company (2021-2026) Table 7. Global Monooxygenase Sales Volume by Company (t) & (2021-2026) Table 8. Global Monooxygenase Sales Volume Share by Company (2021-2026) Table 9. Global Monooxygenase Average Price (USD/t) of Company (2021-2026) Table 10. Global Monooxygenase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Monooxygenase Key Company Manufacturing Base & Headquarters Table 12. Global Monooxygenase Company, Product Type & Application Table 13. Global Monooxygenase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Monooxygenase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of P450 Type Table 18. Significant Companies of Flavin-dependent Type Table 19. Significant Companies of Non-heme Iron Type Table 20. Global Monooxygenase Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Monooxygenase Sales Volume by Type (2021-2026) & (t) Table 22. Global Monooxygenase Sales Volume by Type (2027-2032) & (t) Table 23. Global Monooxygenase Sales Volume Share by Type (2021-2026) Table 24. Global Monooxygenase Sales Volume Share by Type (2027-2032) Table 25. Global Monooxygenase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Monooxygenase Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Monooxygenase Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Monooxygenase Sales Value Share by Type (2021-2026) Table 29. Global Monooxygenase Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharmaceutical Biocatalysis Table 31. Significant Companies of Agrochemical Intermediate Table 32. Significant Companies of Flavor and Fragrance Table 33. Significant Companies of Environmental Remediation Table 34. Significant Companies of Other Table 35. Global Monooxygenase Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Monooxygenase Sales Volume by Application (2021-2026) & (t) Table 37. Global Monooxygenase Sales Volume by Application (2027-2032) & (t) Table 38. Global Monooxygenase Sales Volume Share by Application (2021-2026) Table 39. Global Monooxygenase Sales Volume Share by Application (2027-2032) Table 40. Global Monooxygenase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Monooxygenase Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Monooxygenase Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Monooxygenase Sales Value Share by Application (2021-2026) Table 44. Global Monooxygenase Sales Value Share by Application (2027-2032) Table 45. Global Monooxygenase Sales by Region: 2021 VS 2025 VS 2032 (t) Table 46. Global Monooxygenase Sales by Region (2021-2026) & (t) Table 47. Global Monooxygenase Sales Market Share by Region (2021-2026) Table 48. Global Monooxygenase Sales by Region (2027-2032) & (t) Table 49. Global Monooxygenase Sales Market Share by Region (2027-2032) Table 50. Global Monooxygenase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Monooxygenase Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Monooxygenase Sales Value Share by Region (2021-2026) Table 53. Global Monooxygenase Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Monooxygenase Sales Value Share by Region (2027-2032) Table 55. Global Monooxygenase Market Average Price (USD/t) by Region (2021-2026) Table 56. Global Monooxygenase Market Average Price (USD/t) by Region (2027-2032) Table 57. Global Monooxygenase Sales by Country: 2021 VS 2025 VS 2032 (t) Table 58. Global Monooxygenase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Monooxygenase Sales by Country (2021-2026) & (t) Table 60. Global Monooxygenase Sales Market Share by Country (2021-2026) Table 61. Global Monooxygenase Sales by Country (2027-2032) & (t) Table 62. Global Monooxygenase Sales Market Share by Country (2027-2032) Table 63. Global Monooxygenase Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Monooxygenase Sales Value Market Share by Country (2021-2026) Table 65. Global Monooxygenase Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Monooxygenase Sales Value Market Share by Country (2027-2032) Table 67. Codexis Company Information Table 68. Codexis Business Overview Table 69. Codexis Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. Codexis Monooxygenase Product Portfolio Table 71. Codexis Recent Development Table 72. Almac Group Company Information Table 73. Almac Group Business Overview Table 74. Almac Group Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Almac Group Monooxygenase Product Portfolio Table 76. Almac Group Recent Development Table 77. Prozomix Company Information Table 78. Prozomix Business Overview Table 79. Prozomix Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. Prozomix Monooxygenase Product Portfolio Table 81. Prozomix Recent Development Table 82. InnoSyn Company Information Table 83. InnoSyn Business Overview Table 84. InnoSyn Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. InnoSyn Monooxygenase Product Portfolio Table 86. InnoSyn Recent Development Table 87. Nanjing Predicte Biotechnology Company Information Table 88. Nanjing Predicte Biotechnology Business Overview Table 89. Nanjing Predicte Biotechnology Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. Nanjing Predicte Biotechnology Monooxygenase Product Portfolio Table 91. Nanjing Predicte Biotechnology Recent Development Table 92. SyncoZymes Company Information Table 93. SyncoZymes Business Overview Table 94. SyncoZymes Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. SyncoZymes Monooxygenase Product Portfolio Table 96. SyncoZymes Recent Development Table 97. Asymchem Company Information Table 98. Asymchem Business Overview Table 99. Asymchem Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. Asymchem Monooxygenase Product Portfolio Table 101. Asymchem Recent Development Table 102. WuXi STA Company Information Table 103. WuXi STA Business Overview Table 104. WuXi STA Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. WuXi STA Monooxygenase Product Portfolio Table 106. WuXi STA Recent Development Table 107. Tianjin Bio-Pharmacn Biotechnology Company Information Table 108. Tianjin Bio-Pharmacn Biotechnology Business Overview Table 109. Tianjin Bio-Pharmacn Biotechnology Monooxygenase Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. Tianjin Bio-Pharmacn Biotechnology Monooxygenase Product Portfolio Table 111. Tianjin Bio-Pharmacn Biotechnology Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Monooxygenase Distributors List Table 115. Monooxygenase Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Monooxygenase Product Image Figure 2. Global Monooxygenase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Monooxygenase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Monooxygenase Sales (2021-2032) & (t) Figure 5. Global Monooxygenase Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Monooxygenase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. P450 Type Image Figure 10. Flavin-dependent Type Image Figure 11. Non-heme Iron Type Image Figure 12. Global Monooxygenase Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Monooxygenase Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Monooxygenase Sales Volume Share by Type (2021-2032) Figure 15. Global Monooxygenase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Monooxygenase Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Monooxygenase Sales Value Share by Type (2021-2032) Figure 18. Pharmaceutical Biocatalysis Image Figure 19. Agrochemical Intermediate Image Figure 20. Flavor and Fragrance Image Figure 21. Environmental Remediation Image Figure 22. Other Image Figure 23. Global Monooxygenase Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 24. Global Monooxygenase Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Monooxygenase Sales Volume Share by Application (2021-2032) Figure 26. Global Monooxygenase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Monooxygenase Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Monooxygenase Sales Value Share by Application (2021-2032) Figure 29. Global Monooxygenase Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 30. Global Monooxygenase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Monooxygenase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Monooxygenase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Monooxygenase Sales Value (2021-2032) & (US$ Million) Figure 34. North America Monooxygenase Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Monooxygenase Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Monooxygenase Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Monooxygenase Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Monooxygenase Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Monooxygenase Sales Value (2021-2032) & (US$ Million) Figure 40. South America Monooxygenase Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Monooxygenase Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Monooxygenase Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Monooxygenase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Monooxygenase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Monooxygenase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Monooxygenase Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Monooxygenase Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • P450 Type
  • Flavin-dependent Type
  • Non-heme Iron Type
Applications
  • Pharmaceutical Biocatalysis
  • Agrochemical Intermediate
  • Flavor and Fragrance
  • Environmental Remediation
  • Other
Companies covered
  • Codexis
  • Almac Group
  • Prozomix
  • InnoSyn
  • Nanjing Predicte Biotechnology
  • SyncoZymes
  • Asymchem
  • WuXi STA
  • Tianjin Bio-Pharmacn Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Monooxygenase Sales Value (2021-2032)
  4. 1.2.2 Global Monooxygenase Sales Volume (2021-2032)
  5. 1.2.3 Global Monooxygenase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Monooxygenase Market Dynamics
  1. 2.1 Monooxygenase Industry Trends
  2. 2.2 Monooxygenase Industry Drivers
  3. 2.3 Monooxygenase Industry Opportunities and Challenges
  4. 2.4 Monooxygenase Industry Restraints
3 Monooxygenase Market by Company
  1. 3.1 Global Monooxygenase Company Revenue Ranking in 2025
  2. 3.2 Global Monooxygenase Revenue by Company (2021-2026)
  3. 3.3 Global Monooxygenase Sales Volume by Company (2021-2026)
  4. 3.4 Global Monooxygenase Average Price by Company (2021-2026)
  5. 3.5 Global Monooxygenase Company Ranking (2024-2026)
  6. 3.6 Global Monooxygenase Company Manufacturing Base and Headquarters
  7. 3.7 Global Monooxygenase Company Product Type and Application
  8. 3.8 Global Monooxygenase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Monooxygenase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Monooxygenase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Monooxygenase Market by Type
  1. 4.1 Monooxygenase Type Introduction
  2. 4.1.1 P450 Type
  3. 4.1.2 Flavin-dependent Type
  4. 4.1.3 Non-heme Iron Type
  5. 4.2 Global Monooxygenase Sales Volume by Type
  6. 4.2.1 Global Monooxygenase Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Monooxygenase Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Monooxygenase Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Monooxygenase Sales Value by Type
  10. 4.3.1 Global Monooxygenase Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Monooxygenase Sales Value by Type (2021-2032)
  12. 4.3.3 Global Monooxygenase Sales Value Share by Type (2021-2032)
5 Monooxygenase Market by Application
  1. 5.1 Monooxygenase Application Introduction
  2. 5.1.1 Pharmaceutical Biocatalysis
  3. 5.1.2 Agrochemical Intermediate
  4. 5.1.3 Flavor and Fragrance
  5. 5.1.4 Environmental Remediation
  6. 5.1.5 Other
  7. 5.2 Global Monooxygenase Sales Volume by Application
  8. 5.2.1 Global Monooxygenase Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Monooxygenase Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Monooxygenase Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Monooxygenase Sales Value by Application
  12. 5.3.1 Global Monooxygenase Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Monooxygenase Sales Value by Application (2021-2032)
  14. 5.3.3 Global Monooxygenase Sales Value Share by Application (2021-2032)
6 Monooxygenase Regional Sales and Value Analysis
  1. 6.1 Global Monooxygenase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Monooxygenase Sales by Region (2021-2032)
  3. 6.2.1 Global Monooxygenase Sales by Region: 2021-2026
  4. 6.2.2 Global Monooxygenase Sales by Region (2027-2032)
  5. 6.3 Global Monooxygenase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Monooxygenase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Monooxygenase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Monooxygenase Sales Value by Region (2027-2032)
  9. 6.5 Global Monooxygenase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Monooxygenase Sales Value (2021-2032)
  12. 6.6.2 North America Monooxygenase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Monooxygenase Sales Value (2021-2032)
  15. 6.7.2 Europe Monooxygenase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Monooxygenase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Monooxygenase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Monooxygenase Sales Value (2021-2032)
  21. 6.9.2 South America Monooxygenase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Monooxygenase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Monooxygenase Sales Value Share by Country, 2025 VS 2032
7 Monooxygenase Country-level Sales and Value Analysis
  1. 7.1 Global Monooxygenase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Monooxygenase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Monooxygenase Sales by Country (2021-2032)
  4. 7.3.1 Global Monooxygenase Sales by Country (2021-2026)
  5. 7.3.2 Global Monooxygenase Sales by Country (2027-2032)
  6. 7.4 Global Monooxygenase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Monooxygenase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Monooxygenase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Monooxygenase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Monooxygenase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Monooxygenase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Monooxygenase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Monooxygenase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Monooxygenase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Monooxygenase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Monooxygenase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Monooxygenase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Monooxygenase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Monooxygenase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Monooxygenase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Monooxygenase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Monooxygenase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Monooxygenase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Monooxygenase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Monooxygenase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Monooxygenase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Monooxygenase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Monooxygenase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Monooxygenase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Monooxygenase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Monooxygenase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Monooxygenase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Monooxygenase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Monooxygenase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Monooxygenase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Monooxygenase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Monooxygenase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Monooxygenase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Monooxygenase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Monooxygenase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Monooxygenase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Monooxygenase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Monooxygenase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Monooxygenase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Monooxygenase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Monooxygenase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Monooxygenase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Monooxygenase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Monooxygenase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Monooxygenase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Monooxygenase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Monooxygenase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Monooxygenase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Monooxygenase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Monooxygenase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Monooxygenase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Monooxygenase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Monooxygenase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Monooxygenase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Monooxygenase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Monooxygenase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Monooxygenase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Monooxygenase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Monooxygenase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Monooxygenase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Monooxygenase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Monooxygenase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Monooxygenase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Monooxygenase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Monooxygenase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Monooxygenase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Monooxygenase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Monooxygenase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Monooxygenase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Monooxygenase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Monooxygenase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Monooxygenase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Monooxygenase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Monooxygenase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Monooxygenase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Monooxygenase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Monooxygenase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Monooxygenase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Monooxygenase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Monooxygenase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Monooxygenase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Monooxygenase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Monooxygenase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Monooxygenase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Monooxygenase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Monooxygenase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Monooxygenase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Codexis
  2. 8.1.1 Codexis Company Information
  3. 8.1.2 Codexis Business Overview
  4. 8.1.3 Codexis Monooxygenase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Codexis Monooxygenase Product Portfolio
  6. 8.1.5 Codexis Recent Developments
  7. 8.2 Almac Group
  8. 8.2.1 Almac Group Company Information
  9. 8.2.2 Almac Group Business Overview
  10. 8.2.3 Almac Group Monooxygenase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Almac Group Monooxygenase Product Portfolio
  12. 8.2.5 Almac Group Recent Developments
  13. 8.3 Prozomix
  14. 8.3.1 Prozomix Company Information
  15. 8.3.2 Prozomix Business Overview
  16. 8.3.3 Prozomix Monooxygenase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Prozomix Monooxygenase Product Portfolio
  18. 8.3.5 Prozomix Recent Developments
  19. 8.4 InnoSyn
  20. 8.4.1 InnoSyn Company Information
  21. 8.4.2 InnoSyn Business Overview
  22. 8.4.3 InnoSyn Monooxygenase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 InnoSyn Monooxygenase Product Portfolio
  24. 8.4.5 InnoSyn Recent Developments
  25. 8.5 Nanjing Predicte Biotechnology
  26. 8.5.1 Nanjing Predicte Biotechnology Company Information
  27. 8.5.2 Nanjing Predicte Biotechnology Business Overview
  28. 8.5.3 Nanjing Predicte Biotechnology Monooxygenase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nanjing Predicte Biotechnology Monooxygenase Product Portfolio
  30. 8.5.5 Nanjing Predicte Biotechnology Recent Developments
  31. 8.6 SyncoZymes
  32. 8.6.1 SyncoZymes Company Information
  33. 8.6.2 SyncoZymes Business Overview
  34. 8.6.3 SyncoZymes Monooxygenase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SyncoZymes Monooxygenase Product Portfolio
  36. 8.6.5 SyncoZymes Recent Developments
  37. 8.7 Asymchem
  38. 8.7.1 Asymchem Company Information
  39. 8.7.2 Asymchem Business Overview
  40. 8.7.3 Asymchem Monooxygenase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Asymchem Monooxygenase Product Portfolio
  42. 8.7.5 Asymchem Recent Developments
  43. 8.8 WuXi STA
  44. 8.8.1 WuXi STA Company Information
  45. 8.8.2 WuXi STA Business Overview
  46. 8.8.3 WuXi STA Monooxygenase Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 WuXi STA Monooxygenase Product Portfolio
  48. 8.8.5 WuXi STA Recent Developments
  49. 8.9 Tianjin Bio-Pharmacn Biotechnology
  50. 8.9.1 Tianjin Bio-Pharmacn Biotechnology Company Information
  51. 8.9.2 Tianjin Bio-Pharmacn Biotechnology Business Overview
  52. 8.9.3 Tianjin Bio-Pharmacn Biotechnology Monooxygenase Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Tianjin Bio-Pharmacn Biotechnology Monooxygenase Product Portfolio
  54. 8.9.5 Tianjin Bio-Pharmacn Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Monooxygenase Value Chain Analysis
  2. 9.1.1 Monooxygenase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Monooxygenase Sales Mode & Process
  6. 9.2 Monooxygenase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Monooxygenase Distributors
  9. 9.2.3 Monooxygenase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst